Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Connors

Showing results (641-650 of 977) with videos related to

Pageof 98
Sort By:
Journal of the American College of Cardiology|August 29, 2022
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 PandemicIoannis T Farmakis, Luca Valerio, Behnood Bikdeli, et al.
European Journal of Heart Failure|June 18, 2021
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trialMandeep R Mehra, Daniel L Crandall, Finn Gustafsson, et al.
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Blood Advances|March 8, 2021
Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclinesAlden A Moccia, Kimberly Schaff, Ciara Freeman, et al.
Anesthesiology|October 8, 1997
Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteersJ F Hoke, D Shlugman, M Dershwitz, et al.
Blood|November 16, 2006
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPLaurie H Sehn, Brian Berry, Mukesh Chhanabhai, et al.
Vaccine|May 26, 2009
A systems approach to improving timeliness of immunisationRoss S Bailie, Damin Si, Michelle C Dowden, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Cancer|January 15, 2005
The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer AgencyTamara N Shenkier, Nicholas Voss, Mukesh Chhanabhai, et al.
Leukemia & Lymphoma|June 20, 2007
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphomaKenneth S Wilson, Laurie H Sehn, Brian Berry, et al.
Pageof 98

Showing results (641-650 of 977) with videos related to

Sort By:
Pageof 98
Journal of the American College of Cardiology|August 29, 2022
Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 PandemicIoannis T Farmakis, Luca Valerio, Behnood Bikdeli, et al.
European Journal of Heart Failure|June 18, 2021
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trialMandeep R Mehra, Daniel L Crandall, Finn Gustafsson, et al.
Haematologica|March 26, 2017
Venous thromboembolism is associated with graft-<i>versus</i>-host disease and increased non-relapse mortality after allogeneic hematopoietic stem cell transplantationNatasha Kekre, Haesook T Kim, Vincent T Ho, et al.
Blood Advances|March 8, 2021
Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclinesAlden A Moccia, Kimberly Schaff, Ciara Freeman, et al.
Anesthesiology|October 8, 1997
Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteersJ F Hoke, D Shlugman, M Dershwitz, et al.
Blood|November 16, 2006
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOPLaurie H Sehn, Brian Berry, Mukesh Chhanabhai, et al.
Vaccine|May 26, 2009
A systems approach to improving timeliness of immunisationRoss S Bailie, Damin Si, Michelle C Dowden, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 10, 2021
Intracerebral haemorrhage in patients with brain metastases receiving therapeutic anticoagulationPeter Wood, Giovanni Boyer, Elie Mehanna, et al.
Cancer|January 15, 2005
The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer AgencyTamara N Shenkier, Nicholas Voss, Mukesh Chhanabhai, et al.
Leukemia & Lymphoma|June 20, 2007
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphomaKenneth S Wilson, Laurie H Sehn, Brian Berry, et al.
Pageof 98